What is the recommended dose of ivermectin for the treatment of head lice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ivermectin Dosing for Head Lice Treatment

For head lice treatment, oral ivermectin is recommended at a single dose of 200 μg/kg (micrograms per kilogram) of body weight, repeated in 7-10 days, for patients who weigh at least 15 kg. 1, 2

Oral Ivermectin Dosing Protocol

  • Patient Selection:

    • Only use in patients weighing ≥15 kg (33 lbs)
    • Not recommended for children under this weight threshold due to risk of ivermectin crossing the blood-brain barrier 1
    • Consider as second or third-line therapy after failure of topical treatments
  • Dosing Regimen:

    • Initial dose: 200 μg/kg as a single oral dose
    • Follow-up dose: Repeat same dose in 7-10 days to kill newly hatched lice 1, 3
    • Some evidence suggests that a higher dose of 400 μg/kg may be more effective against difficult-to-treat cases 3

Topical Ivermectin Alternative

If oral administration is not preferred, topical ivermectin is an alternative:

  • 0.5% ivermectin lotion applied for 10 minutes as a single application 4, 5
  • This concentration has shown superior efficacy (73.7% eradication) compared to lower concentrations 4
  • Only requires one application due to its ability to prevent newly hatched lice from feeding 5

Efficacy Considerations

  • Oral ivermectin has shown cure rates of 77.5% after a single dose and 92.5% after a second dose 6
  • In difficult-to-treat cases, oral ivermectin (400 μg/kg) demonstrated superior efficacy (95.2% lice-free rate) compared to malathion lotion (85.0%) 3
  • Topical ivermectin 0.5% lotion has demonstrated effectiveness against permethrin-resistant lice 7

Safety Considerations and Precautions

  • Important safety warnings:

    • Ivermectin may cross the blood-brain barrier and block essential neural transmission
    • Young children may be at higher risk of adverse reactions 1
    • Monitor for rare neurological side effects
  • Common adverse effects:

    • Oral: Generally well-tolerated with minimal side effects
    • Topical: Pruritus (0.9% of patients) 5

Treatment Algorithm

  1. First-line treatment: Permethrin 1% or pyrethrins (according to AAP guidelines) 2
  2. Second-line treatment: Malathion 0.5% lotion if first-line treatment fails 2
  3. Third-line treatment: Consider ivermectin when previous treatments have failed:
    • For patients ≥15 kg: Oral ivermectin 200 μg/kg, repeated in 7-10 days
    • Alternative: Topical ivermectin 0.5% lotion as a single application

Common Pitfalls to Avoid

  • Using ivermectin in children weighing less than 15 kg
  • Failure to administer the second dose of oral ivermectin (when using oral formulation)
  • Misdiagnosis of active infestation (confirm presence of live lice before treatment)
  • Overuse of pediculicides leading to resistance
  • Inadequate environmental cleaning measures

Remember that neither oral nor topical ivermectin formulations were FDA-approved specifically for head lice treatment at the time of the 2010 American Academy of Pediatrics guideline publication 1, though they have shown significant efficacy in clinical studies.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Head Lice Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical ivermectin 0.5% lotion for treatment of head lice.

The Annals of pharmacotherapy, 2013

Research

Oral ivermectin for head lice: a comparison with 0.5 % topical malathion lotion.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.